BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 27084103)

  • 1. POSH Regulates CD4+ T Cell Differentiation and Survival.
    Cunningham CA; Cardwell LN; Guan Y; Teixeiro E; Daniels MA
    J Immunol; 2016 May; 196(10):4003-13. PubMed ID: 27084103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The POSH/JIP-1 scaffold network regulates TCR-mediated JNK1 signals and effector function in CD8(+) T cells.
    Cunningham CA; Knudson KM; Peng BJ; Teixeiro E; Daniels MA
    Eur J Immunol; 2013 Dec; 43(12):3361-71. PubMed ID: 23963642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Akt2 negatively regulates assembly of the POSH-MLK-JNK signaling complex.
    Figueroa C; Tarras S; Taylor J; Vojtek AB
    J Biol Chem; 2003 Nov; 278(48):47922-7. PubMed ID: 14504284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. POSH acts as a scaffold for a multiprotein complex that mediates JNK activation in apoptosis.
    Xu Z; Kukekov NV; Greene LA
    EMBO J; 2003 Jan; 22(2):252-61. PubMed ID: 12514131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The scaffold protein POSH regulates axon outgrowth.
    Taylor J; Chung KH; Figueroa C; Zurawski J; Dickson HM; Brace EJ; Avery AW; Turner DL; Vojtek AB
    Mol Biol Cell; 2008 Dec; 19(12):5181-92. PubMed ID: 18829867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The adaptor molecule CD2AP in CD4 T cells modulates differentiation of follicular helper T cells during chronic LCMV infection.
    Raju S; Kometani K; Kurosaki T; Shaw AS; Egawa T
    PLoS Pathog; 2018 May; 14(5):e1007053. PubMed ID: 29734372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sh3rf2/POSHER protein promotes cell survival by ring-mediated proteasomal degradation of the c-Jun N-terminal kinase scaffold POSH (Plenty of SH3s) protein.
    Wilhelm M; Kukekov NV; Schmit TL; Biagas KV; Sproul AA; Gire S; Maes ME; Xu Z; Greene LA
    J Biol Chem; 2012 Jan; 287(3):2247-56. PubMed ID: 22128169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Entry of CD4-CD8- immature thymocytes into the CD4/CD8 developmental pathway is controlled by tyrosine kinase signals that can be provided through TCR components.
    Takahama Y; Hasegawa T; Itohara S; Ball EL; Sheard MA; Hashimoto Y
    Int Immunol; 1994 Oct; 6(10):1505-14. PubMed ID: 7826942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of p38 mitogen-activated protein kinase in vivo selectively induces apoptosis of CD8(+) but not CD4(+) T cells.
    Merritt C; Enslen H; Diehl N; Conze D; Davis RJ; Rincón M
    Mol Cell Biol; 2000 Feb; 20(3):936-46. PubMed ID: 10629051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. c-Jun NH(2)-terminal kinase (JNK)1 and JNK2 signaling pathways have divergent roles in CD8(+) T cell-mediated antiviral immunity.
    Arbour N; Naniche D; Homann D; Davis RJ; Flavell RA; Oldstone MB
    J Exp Med; 2002 Apr; 195(7):801-10. PubMed ID: 11927625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new rac target POSH is an SH3-containing scaffold protein involved in the JNK and NF-kappaB signalling pathways.
    Tapon N; Nagata K; Lamarche N; Hall A
    EMBO J; 1998 Mar; 17(5):1395-404. PubMed ID: 9482736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. POSH is an intracellular signal transducer for the axon outgrowth inhibitor Nogo66.
    Dickson HM; Zurawski J; Zhang H; Turner DL; Vojtek AB
    J Neurosci; 2010 Oct; 30(40):13319-25. PubMed ID: 20926658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Knock-down of POSH expression is neuroprotective through down-regulating activation of the MLK3-MKK4-JNK pathway following cerebral ischaemia in the rat hippocampal CA1 subfield.
    Zhang QG; Wang RM; Yin XH; Pan J; Xu TL; Zhang GY
    J Neurochem; 2005 Nov; 95(3):784-95. PubMed ID: 16248889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct interaction of the molecular scaffolds POSH and JIP is required for apoptotic activation of JNKs.
    Kukekov NV; Xu Z; Greene LA
    J Biol Chem; 2006 Jun; 281(22):15517-24. PubMed ID: 16571722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of protein kinase C theta, Bcl10, or Malt1 selectively impairs proliferation and NF-kappa B activation in the CD4+ T cell subset.
    Kingeter LM; Schaefer BC
    J Immunol; 2008 Nov; 181(9):6244-54. PubMed ID: 18941215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. POSH localizes activated Rac1 to control the formation of cytoplasmic dilation of the leading process and neuronal migration.
    Yang T; Sun Y; Zhang F; Zhu Y; Shi L; Li H; Xu Z
    Cell Rep; 2012 Sep; 2(3):640-51. PubMed ID: 22959435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. POSH misexpression induces caspase-dependent cell death in Drosophila.
    Lennox AL; Stronach B
    Dev Dyn; 2010 Feb; 239(2):651-64. PubMed ID: 20014406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dual-specificity phosphatase 14 (DUSP14/MKP6) negatively regulates TCR signaling by inhibiting TAB1 activation.
    Yang CY; Li JP; Chiu LL; Lan JL; Chen DY; Chuang HC; Huang CY; Tan TH
    J Immunol; 2014 Feb; 192(4):1547-57. PubMed ID: 24403530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The assembly of POSH-JNK regulates Xenopus anterior neural development.
    Kim GH; Park E; Han JK
    Dev Biol; 2005 Oct; 286(1):256-69. PubMed ID: 16125690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analyzing expression of perforin, Runx3, and Thpok genes during positive selection reveals activation of CD8-differentiation programs by MHC II-signaled thymocytes.
    Liu X; Taylor BJ; Sun G; Bosselut R
    J Immunol; 2005 Oct; 175(7):4465-74. PubMed ID: 16177089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.